Cargando…

Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43

The COVID-19 pandemic has made it clear that there is a crucial need for the design and development of antiviral agents that can efficiently reduce the fatality rate caused by infectious diseases. The fact that coronavirus mainly enters through the nasal epithelial cells and spreads through the nasa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mali, Avinash, Franci, Gianluigi, Zannella, Carla, Chianese, Annalisa, Anthiya, Shubaash, López-Estévez, Ana M., Monti, Alessandra, De Filippis, Anna, Doti, Nunzianna, Alonso, María José, Galdiero, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305280/ https://www.ncbi.nlm.nih.gov/pubmed/37376070 http://dx.doi.org/10.3390/pharmaceutics15061621

Ejemplares similares

Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host
por: Forni, Diego, et al.
Publicado: (2021)

Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2
por: Schirtzinger, Erin E., et al.
Publicado: (2022)

Titration of Human Coronaviruses, HCoV-229E and HCoV-OC43, by an Indirect Immunoperoxidase Assay
por: Lambert, Francine, et al.
Publicado: (2007)

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
por: Fuochi, Virginia, et al.
Publicado: (2023)

Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43
por: Mourez, Thomas, et al.
Publicado: (2007)

HCoV-Oc43–Induced Apoptosis of Murine Neuronal Cells
por: Jacomy, Hélène, et al.
Publicado: (2006)

HCoV-OC43–Induced Encephalitis is in Part Immune-Mediated
por: Butler, Noah, et al.
Publicado: (2006)

The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23
por: Chianese, Annalisa, et al.
Publicado: (2022)

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study
por: Aldridge, Robert W., et al.
Publicado: (2020)

Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
por: Chen, Yongkang, et al.
Publicado: (2022)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
por: Dugas, Martin, et al.
Publicado: (2021)

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
por: Feng, Yongmei, et al.
Publicado: (2022)

Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
por: Kim, Jang Hoon, et al.
Publicado: (2023)

Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo.
por: Ojha, Durbadal, et al.
Publicado: (2023)

Hylin-a1: A Host Defense Peptide with Antibacterial Potential against Staphylococcus aureus Multi-Resistant Strains
por: Chianese, Annalisa, et al.
Publicado: (2023)

Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2
por: Mayes, Cathryn M., et al.
Publicado: (2023)

A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs
por: Xie, Peifang, et al.
Publicado: (2022)

Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
por: Lavell, A.H. Ayesha, et al.
Publicado: (2022)

Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
por: Wang, Xiaohuan, et al.
Publicado: (2022)

The 5′UTR of HCoV-OC43 adopts a topologically constrained structure to intrinsically repress translation
por: Mackeown, Matthew, et al.
Publicado: (2023)

Effect of andrographolide and deep eutectic solvent extracts of Andrographis paniculata on human coronavirus organ culture 43 (HCoV-OC43)
por: Komaikul, Jukrapun, et al.
Publicado: (2023)

Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice
por: Niu, Junwei, et al.
Publicado: (2020)

Evaluating the Impact of gRNA SNPs in CasRx Activity for Reducing Viral RNA in HCoV-OC43
por: Mayes, Cathryn Michelle, et al.
Publicado: (2022)

Design of Three Residues Peptides against SARS-CoV-2 Infection
por: Zannella, Carla, et al.
Publicado: (2022)

Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses
por: Chianese, Annalisa, et al.
Publicado: (2023)

Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication
por: Burgess, Hannah M., et al.
Publicado: (2021)

Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2
por: Pasquero, Selina, et al.
Publicado: (2022)

Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation
por: Dolliver, Stacia M., et al.
Publicado: (2022)

Coronavirus humains (HCoV)
por: Vabret, A., et al.
Publicado: (2009)

Comparative molecular epidemiology of two closely related coronaviruses, bovine coronavirus (BCoV) and human coronavirus OC43 (HCoV-OC43), reveals a different evolutionary pattern
por: KIN, Nathalie, et al.
Publicado: (2016)

Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated
por: Butler, Noah, et al.
Publicado: (2006)

Prevalence of Human Coronaviruses in Children and Phylogenetic Analysis of HCoV-OC43 during 2016–2022 in Riyadh, Saudi Arabia
por: Alamri, Khalid A., et al.
Publicado: (2022)

Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43
por: Demers-Mathieu, Veronique, et al.
Publicado: (2021)

Melittin-Related Peptides Interfere with Sandfly Fever Naples Virus Infection by Interacting with Heparan Sulphate
por: Chianese, Annalisa, et al.
Publicado: (2023)

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
por: Ordonez, Alvaro A., et al.
Publicado: (2022)

Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor
por: Yousefi, Meisam, et al.
Publicado: (2023)

Human Milk Antibodies against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with a Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
por: Demers-Mathieu, Veronique, et al.
Publicado: (2021)

Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells
por: Min, Jung Sun, et al.
Publicado: (2020)

Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 229E) associated with childhood pneumonia in Kilifi, Kenya
por: Otieno, Grieven P., et al.
Publicado: (2020)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhlpbfom9kq9ng2ouos53555k7